home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stabilization Contra Retardation

  April, 19 2007 8:26
your information resource in human molecular genetics
A paper published online in Nature Neuroscience explores the mechanisms underlying fragile X syndrome -- the most common inherited form of mental retardation.

This disorder is caused by loss of a protein, dubbed FMRP, which interacts with messenger RNAs. (mRNAs are the templates that a cell "reads" to correctly build specific proteins.) The details of how FMRP affects mRNAs and protein synthesis, and how subtle misregulation in absence of FMRP causes mental retardation, are still unclear.

Claudia Bagni and Kirsten S Dickson and colleagues now report that FMRP stabilizes the mRNA that encodes the protein PSD-95. PSD-95 is crucial for the structure and function of neural synapses. In the brains of mice lacking FMRP, the authors found that the PSD-95 mRNA was rapidly degraded. The level of PSD-95 protein was reduced especially in the hippocampus, a structure crucial for learning, memory and certain kinds of reasoning.

This work suggests an important role for mRNA stabilization in the circuit wiring and communication of nerve cell networks. Though it is unlikely that all fragile X mental retardation symptoms can be explained by instability of PSD-95 mRNA, it may well represent an important part of the disease mechanism.

Author contacts:

Claudia Bagni (Universita di Roma, Italy)
E-mail: claudia.bagni@uniroma2.it

Kirsten S. Dickson (University of Edinburgh, UK)
E-mail: dickson.kris@gmail.com

Abstract available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.